1. Albert J, Chessari G, Congreve MS, Edwards P, Murray C, Patel S, et al. 2007a. Preparation of dihydroisoquinolin-1-amines for treating or preventing Ab related pathologies such as cognitive impairment, Alzheimer's disease, neurodegeneration and dementia. WO patent 2007058583. Astrazeneca AB S, Astex Therapeutics Ltd.
2. Albert J, Chessari G, Edwards P. 2007b. Preparation of substituted 2-aminopyrimidines for treating or preventing Ab-related pathologies. WO patent 2007058581. Astrazeneca AB S, Astex Therapeutics Ltd.
3. Alzheimer's Disease Facts and Figures. 2007. www.alz.org/alzheimersdisease_publications_reports. in press.
4. The novel beta-secretase inhibitor KMI-429 reduces amyloid beta peptide production in amyloid precursor protein transgenic and wild-type mice;Asai;J Neurochem,2006
5. 2-amino-3,4-dihydroquinazolines as inhibitors of BACE-1 (beta-site APP cleaving enzyme): use of structure based design to convert a micromolar hit into a nanomolar lead;Baxter;J Med Chem,2007